This company has been marked as potentially delisted and may not be actively trading. NYSE:XAN Exantas Capital (XAN) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisCompetitorsTrendsBuy This Stock About Exantas Capital Stock (NYSE:XAN) Get Exantas Capital alerts:Sign Up Key Stats Today's Range$20.21▼$20.7250-Day Range$4.34▼$16.1552-Week Range$2.85▼$37.53Volume15,044 shsAverage Volume205,768 shsMarket Capitalization$659.83 millionP/E RatioN/ADividend Yield16.05%Price TargetN/AConsensus RatingN/A Company Overview Exantas Capital Corp., a real estate investment trust, primarily focuses on the origination, holding, and management of commercial real estate mortgage loans and other commercial real estate-related debt investments in the United States. It invests in commercial real estate-related assets, including floating and fixed rate first mortgage loans, first priority interests in first mortgage loans, subordinated interests in first mortgage loans, mezzanine debt, preferred equity investments, commercial mortgage-backed securities, and commercial real estate equity investments. The company qualifies as a real estate investment trust (REIT) for federal income tax purposes. It generally would not be subject to federal corporate income tax to the extent that it distributes 100% of its REIT taxable income. The company was formerly known as Resource Capital Corp. and changed its name to Exantas Capital Corp. in May 2018. Exantas Capital Corp. was founded in 2005 and is based in New York, New York. Read More Receive XAN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Exantas Capital and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. XAN Stock News HeadlinesCapital One CD Rates for January 2024February 3, 2024 | cnet.comCapital One Savings Account Interest Rates: November 2023November 7, 2023 | investopedia.comIs *BSEM* Oversold??BioStem Technologies Inc. (OTC: BSEM) is emerging as one of the most exciting MedTech stories of 2025. The company delivered record-breaking revenues in 2024 and Q1 2025, including $72.5 million in net revenue for Q1 — a 73% increase over the prior year — and six consecutive quarters of positive adjusted EBITDA. With cash reserves rising to $30.8 million and a growing patent portfolio of 58 issued and 68 pending patents, BSEM is scaling profitably while advancing its proprietary BioREtain® technology, which has shown clinically superior results for chronic, non-healing wounds. National recognition is adding to the momentum, with CEO Jason Matuszewski named EY Entrepreneur of the Year 2025 Florida Award winner, validating the leadership driving this high-growth MedTech powerhouse.October 16 at 2:00 AM | Huge Alerts (Ad)ACRES Commercial: Preferreds For Yield, Common For UpsideJune 12, 2023 | msn.comTier 1 Capital: Definition, Components, Ratio, and How It's UsedMarch 30, 2023 | investopedia.comHere's what Wall Street expects from Exantas Capital's earningsMarch 1, 2023 | markets.businessinsider.comCRE Industry Veteran Eric T. Baum Joins Greystone MonticelloAugust 1, 2022 | apnews.comANN Inc (NNBR)July 7, 2022 | es.investing.comSee More Headlines XAN Stock Analysis - Frequently Asked Questions How were Exantas Capital's earnings last quarter? Exantas Capital Corp. (NYSE:XAN) released its quarterly earnings results on Wednesday, November, 4th. The company reported $0.51 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.24 by $0.27. Exantas Capital had a negative net margin of 347.93% and a positive trailing twelve-month return on equity of 8.10%. When did Exantas Capital's stock split? Exantas Capital's stock reverse split on Tuesday, February 16th 2021.The 1-3 reverse split was announced on Thursday, February 4th 2021. The number of shares owned by shareholders was adjusted after the market closes on Monday, February 15th 2021. An investor that had 100 shares of stock prior to the reverse split would have 33 shares after the split. What other stocks do shareholders of Exantas Capital own? Based on aggregate information from My MarketBeat watchlists, some other companies that Exantas Capital investors own include Energy Transfer (ET), New York Mortgage Trust (NYMT), MFA Financial (MFA), BRAEMAR HOTELS & RESORTS (BHR), Ladder Capital (LADR), Redwood Trust (RWT) and Ashford Hospitality Trust (AHT). Company Calendar Last Earnings11/04/2020Today10/16/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorFinance Industry Real Estate Investment Trusts Sub-IndustryN/A Current SymbolNYSE:XAN CIKN/A Webwww.exantas.com Phone516-535-0015FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)$1.00 Trailing P/E RatioN/A Forward P/E Ratio38.79 P/E GrowthN/ANet Income$35.97 million Net Margins-347.93% Pretax MarginN/A Return on Equity8.10% Return on Assets1.61% Debt Debt-to-Equity Ratio5.01 Current Ratio251.90 Quick Ratio251.90 Sales & Book Value Annual Sales$61.15 million Price / Sales10.79 Cash Flow$15.34 per share Price / Cash Flow1.34 Book Value$17.45 per share Price / Book1.18Miscellaneous Outstanding Shares32,093,000Free FloatN/AMarket Cap$659.83 million OptionableNot Optionable Beta1.32 Analysts Agree—These Gold Picks Outshine the RestUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free Report This page (NYSE:XAN) was last updated on 10/16/2025 by MarketBeat.com Staff From Our PartnersIs *BSEM* Oversold??BioStem Technologies Inc. (OTC: BSEM) is emerging as one of the most exciting MedTech stories of 2025. The com...Huge Alerts | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredREVEALED: Something Big Happening Behind White House DoorsWhat I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredShots officially fired…Elon Musk just declared war on the wireless giants with a $17 billion spectrum deal that gives SpaceX the righ...Brownstone Research | SponsoredWall St’s “AI Godfather” breaks his silenceWhats next after AI? Hidden AI. "Hidden AI" could soon be the biggest investment trend of 2025.Chaikin Analytics | SponsoredOptions Pro Reveals His #1 Retirement Income TradeIf you can be at your computer between 9 a.m. and 10:45 a.m. on most weekdays, I’ll show you a simple trading ...Base Camp Trading | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMiss This IRS Strategy Now, Regret It LaterWith Donald Trump back in the White House, many believe an economic revival could be underway — but it also br...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Exantas Capital Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Exantas Capital With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.